Uncategorized
Nicox reports €12.3 million loss in first half of 2016
Nicox reported a net loss of 12.3 million in the first 6 months of 2016, excluding discontinued operations, compared with a net loss of 10.1 million reported during the same period in 2015, according to a press release.Operating expenses totaled 12 million, excluding discontinued operations, compared with 8.8 million a year ago. The increase was attributed to costs associated with the submission of a new drug application to the FDA for AC-170 to treat ocular itching associated with allergic conjunctivitis.